Explore the words cloud of the ImmunoMECH project. It provides you a very rough idea of what is the project "ImmunoMECH" about.
The following table provides information about the project.
UNIVERSITY OF CYPRUS
|Coordinator Country||Cyprus [CY]|
|Total cost||145˙941 €|
|EC max contribution||145˙941 € (100%)|
1. H2020-EU.4. (SPREADING EXCELLENCE AND WIDENING PARTICIPATION)
|Duration (year-month-day)||from 2019-06-17 to 2021-06-16|
Take a look of project's partnership.
|1||UNIVERSITY OF CYPRUS||CY (NICOSIA)||coordinator||145˙941.00|
Inefficient delivery of cellular and molecular medicines to solid tumors can reduce dramatically the efficacy of treatment and affect negatively patient’s survival. This explains in large part why standard chemo- and immune-therapies often fail to treat specific cancer types, even though these therapies are potent enough to eradicate cancer cells. Abnormalities in the structure of the tumor vasculature hinder tumor perfusion and as a result the systemic delivery of the medicines. In many tumor types, blood vessels are hyper-permeable, leaving large interendothelial openings, which causes fluid loss from the vascular to the interstitial tumor space. Vessel hyper-permeability can reduce tumor blood flow, rendering tumors hypo-perfused and hypoxic. Impaired blood supply and hypoxia help cancer cells evade the immune system and increase their invasive and metastatic potential. Normalization of the tumor vasculature is a clinical strategy to repair vascular abnormalities in order to improve perfusion, oxygenation and delivery of medicines. Immunotherapy is gaining interest as an effective therapeutic approach against cancer, but only a subset of patients receiving immunotherapy exhibit sustained tumor shrinkage. Here, we hypothesize that vascular normalization can improve immunotherapy. The objective of the proposed research is the optimal design of the combined immunotherapy and vascular normalization therapeutic approach. To this end, a numerical and experimental study is proposed to model and experimentally validate the vascular normalization procedure, focusing on its combined effects with immunotherapeutic drugs. The proposed research/training will complement the Applicant’s skills in high-performance computing, advanced optimization algorithms and artificial neural networks with the Host’s expertise in tumor microenvironment and cancer drug delivery to enhance his professional maturity and promote international collaborations.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMMUNOMECH" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IMMUNOMECH" are provided by the European Opendata Portal: CORDIS opendata.
Deciphering the effects of locus coeruleus activity on whole-brain dynamics and neurovascular couplingRead More
Dissecting how the Drosophila brain regulates behavioral sequences of feeding to ensure protein homeostasisRead More
Growth balance regulation by SnRK1 under ABA-stress conditionsRead More